Angiostasis-induced vascular normalization can improve photodynamic therapy

Cellular and Molecular Life Sciences

Volumn 67, Issue 9, 2010, Pages 1559-1560

  Nowak Sliwinska, Patrycja ^a   Wagnières, Georges ^a   Van Den Bergh, Hubert ^a   Griffioen, Arjan W ^b  

^a EPFL   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; PHOTOSENSITIZING AGENT; RANIBIZUMAB; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VERTEPORFIN;

ADVANCED CANCER; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; BLOOD VESSEL FUNCTION; CANCER THERAPY; CHOROID TUMOR; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG TARGETING; HEMANGIOMA; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NOTE; OXYGEN TENSION; PHOTOCHEMICAL EFFICIENCY; PHOTODYNAMIC THERAPY; PROTEIN SECRETION; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; SUBRETINAL FLUID; SUPERFICIAL CANCER; TISSUE OXYGENATION; TISSUE PRESSURE; TREATMENT INDICATION; TREATMENT RESPONSE; VISUAL ACUITY; DRUG ANTAGONISM; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952296459     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0294-x     Document Type: Note

References (8)

1. R Bhuvaneswari YY Gan KC Soo M Olivo 2009 The effect of photodynamic therapy on tumor angiogenesis Cell Mol Life Sci 66 2275 2283 10.1007/s00018-009-0016-4 1:CAS:528:DC%2BD1MXot12ltrY%3D 19333552
2. RK Jain 2005 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 58 62 10.1126/science.1104819 1:CAS:528:DC%2BD2MXnvFar 15637262 (Pubitemid 40093472)
3. RP Dings M Loren H Heun E McNiel AW Griffioen KH Mayo RJ Griffin 2007 Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization Clin Cancer Res 13 3395 3402 10.1158/1078-0432.CCR-06-2441 1:CAS:528:DC%2BD2sXmtVaisrY%3D 17545548 (Pubitemid 46944928)
4. M Sagong J Lee W Chang 2009 Application of intravitreal bevacizumab for circumscribed choroidal hemangioma Korean J Ophthalmol 23 127 131 10.3341/kjo.2009.23.2.127 19568366
5. B Kosharskyy N Solban SK Chang I Rizvi Y Chang T Hasan 2006 A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer Cancer Res 66 10953 10958 10.1158/0008-5472.CAN-06-1793 1:CAS:528:DC%2BD2sXivVyqtrY%3D 17108133 (Pubitemid 44876994)
6. HM Verheul HM Pinedo 2007 Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition Nat Rev Cancer 7 475 485 10.1038/nrc2152 1:CAS:528:DC%2BD2sXls1Kjsb4%3D 17522716 (Pubitemid 46809172)
7. JO Curwen HL Musgrove J Kendrew GH Richmond DJ Ogilvie SR Wedge 2008 Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (Recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy Clin Cancer Res 14 3124 3131 10.1158/1078-0432.CCR-07-4783 1:CAS:528: DC%2BD1cXmtVCmurw%3D 18483380
8. PK Wong F Yu A Shahangian G Cheng R Sun CM Ho 2008 Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm Proc Natl Acad Sci USA 105 5105 5110 10.1073/pnas.0800823105 1:CAS:528:DC%2BD1cXksVCgurg%3D 18356295 (Pubitemid 351738517)